NEW YORK, June 4, 2002 (PRIMEZONE) -- StockDiagnostics.com announces Philip Morris Companies Inc.'s OPS (Operational-cashflow Per Share) for its first-quarter and twelve-months ended March 31, 2002. OPS increased 104% for the first-quarter and 18% for the twelve-months ended March 31, 2002 over the comparable periods ended March 31, 2001.
To view four-quarter, twenty-quarter and five-year OPS charts on Philip Morris (NYSE:MO) and over 7,500 public companies, go to: http://www.stockdiagnostics.com
Philip Morris' computed OPS (Operational-cashflow Per Share) for its first-quarter ended March 31, 2002, was $0.51, an increase of 104% over its OPS of $0.25 for its first-quarter ended March 31, 2001. For the trailing 12-months ended March 31, 2002, Philip Morris' OPS increased to $4.36 an increase of 18% as compared to its OPS of $3.71 for the twelve-months ended March 31, 2001.
What is OPS?
OPS(TM) stands for "Operational-cashflow Per Share." It is derived from the line item "Cash Flow from Operations" which appears in a company's quarterly and annual Cash Flow Statements filed with the Securities & Exchange Commission. "OPS" is calculated by dividing a company's Cash Flow from Operations by the total number of shares outstanding. After conducting in-depth research on Operational-cashflow Per Share, StockDiagnostics.com determined that OPS can be used to measure the quality of a company's EPS and for monitoring its overall financial health. Cash Flow from Operations is a company's financial lifeblood and a sudden decrease in it can drain this lifeblood, causing an increase in debt, share dilution, share price erosion, and in the more extreme cases, bankruptcy.
For more information on OPS go to: http://www.stockdiagnostics.com/member/ops.htm
About StockDiagnostics.com
StockDiagnostics.com has designed and built a proprietary data refinery that automates the process of collecting, sorting, and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement and securities pricing variances or anomalies and to monitor changes in the performance of public companies.
For more information on StockDiagnostics.com go to: http://www.stockdiagnostics.com/member/help.htm#a1
OPS, OPS Ratings, and The EPS Syndrome are all Trademarks (TM) of StockDiagnostics.com.